Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

This study has been withdrawn prior to enrollment.

(Funding source was terminated before enrollment of first subject)

Sponsor:

Collaborator:

Amgen

Information provided by (Responsible Party):

UNC Lineberger Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT01312493

First received: March 8, 2011

Last updated: May 22, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	December 2018
Estimated Primary Completion Date:	December 2017 (Final data collection date for primary outcome measure)